drugset / Trial / NCT03090919

The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis

NCT03090919

Withdrawn Susan Smyth
RandomizedParallel-groupOpen-labelTreatment

Summary

Sepsis is life-threatening and dysregulated response to infection that results in endothelial activation and dysfunction that leads to systemic microvascular leak and multiple-organ failure. This study will identify patients that have sepsis with thrombocytopenia and randomize them to receive a unit of platelets or an equivalent volume of saline.

Timeline

Start
2017-01-03
Primary completion
2021-05-31
Completion
2021-05-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet transfusion Unknown 250 ml